NUTM1 and acute lymphoblastic leukemia: First, in both bulk mRNA and single-cell analyses, NUTM1-rearranged infant B-ALL, recently identified to carry a favorable prognosis6, exhibited cell signals away from the ELP state and more reminiscent of standard-risk B-ALL.